Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 6/20 | 0.43 |
| ▸ | CNR1 | P21554 | 4/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.42 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | TACR3 | P29371 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1826965 | 1.00 | KDM4E (0.49) | KDM4EKMT2AL3MBTL1CNR2CNR1 | |
| SCHEMBL2028355 | 1.00 | KDM4E (0.49) | KDM4EKMT2AL3MBTL1CNR2CNR1 | |
| SCHEMBL3740930 | 1.00 | KDM4E (0.49) | KDM4EKMT2AL3MBTL1CNR2CNR1 | |
| SCHEMBL8015861 | 1.00 | KDM4E (0.49) | KDM4EKMT2AL3MBTL1CNR2CNR1 | |
| SCHEMBL2536987 | 1.00 | KDM4E (0.49) | KDM4EKMT2AL3MBTL1CNR2CNR1 | |
| SCHEMBL2024342 | 1.00 | KDM4E (0.49) | KDM4EKMT2AL3MBTL1CNR2CNR1 | |
| SCHEMBL451183 | 1.00 | KDM4E (0.49) | KDM4EKMT2AL3MBTL1CNR2CNR1 | |
| SCHEMBL5156697 | 0.99 | KDM4E (0.47) | KDM4EKMT2AL3MBTL1CNR2CNR1 | |
| SCHEMBL6842064 | 0.94 | ALOX5 (0.44) | KDM4EKMT2AL3MBTL1ALOX5CYP2C9 | |
| SCHEMBL5351493 | 0.92 | FAAH (0.45) | KDM4EKMT2AL3MBTL1CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3478514-B1 | COMPOSITION COMPRISING ESTERS | HANSEN & ROSENTHAL KG (DE) | 2020-03-25 | — | — | EP | disclosed |
| EP-1435978-B1 | ESTERS OF AROMATIC ALKOXYLATED ALCOHOLS AND FATTY CARBOXYLIC ACIDS | CRODA INC (US) | 2014-09-03 | — | — | EP | disclosed |
| CN-1571765-B | Esters of aromatic alkoxylated alcohols and fatty carboxylic acids | CRODA INC | 2012-09-26 | — | — | CN | disclosed |
| US-7217424-B2 | Compositions containing esters of aromatic alkoxylated alcohols and fatty carboxylic acids | CRODA, INC. (US) | 2007-05-15 | — | — | US | disclosed |
| EP-1435978-A4 | ESTERS OF AROMATIC ALKOXYLATED ALCOHOLS AND FATTY CARBOXYLIC ACIDS | CRODA INC (US) | 2006-05-17 | — | — | EP | disclosed |
| US-6987195-B2 | Esters of aromatic alkoxylated alcohols and fatty carboxylic acids | CRODA, INC. (US) | 2006-01-17 | — | — | US | disclosed |
| CN-1571765-A | Esters of aromatic alkoxylated alcohols and fatty carboxylic acids | CRODA INC (US) | 2005-01-26 | — | — | CN | disclosed |
| EP-1435978-A2 | ESTERS OF AROMATIC ALKOXYLATED ALCOHOLS AND FATTY CARBOXYLIC ACIDS | Croda, Inc. (US) | 2004-07-14 | — | — | EP | disclosed |
| US-20030181744-A1 | Esters of aromatic alkoxylated alcohols and fatty carboxylic acids | CRODA, INC. | 2003-09-25 | — | — | US | disclosed |
| US-20030161792-A1 | Compositions containing esters of aromatic alkoxylated alcohols and fatty carboxylic acids | CRODA, INC. | 2003-08-28 | — | — | US | disclosed |
| WO-2003032919-A2 | ESTERS OF AROMATIC ALKOXYLATED ALCOHOLS AND FATTY CARBOXYLIC ACIDS | CRODA, INC. (US) | 2003-04-24 | — | — | WO | disclosed |
| US-5683691-A | Bacillus thuringiensis insecticidal toxins | PLANT GENETIC SYSTEMS, N.V. (BE) | 1997-11-04 | — | — | US | disclosed |
| EP-0382990-A1 | Strains of bacillus thuringiensis | PLANT GENETIC SYSTEMS, N.V. (BE) | 1990-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030161792-A1 | Compositions containing esters of aromatic alkoxylated alcohols and fatty carboxylic acids | AHR, ARNT, TYR | KDM4E 364/4885KMT2A 3069/4885L3MBTL1 3887/4885 |
| US-20030181744-A1 | Esters of aromatic alkoxylated alcohols and fatty carboxylic acids | FABP4, CUTA, ALK | KDM4E 1562/4885KMT2A 3307/4885L3MBTL1 4246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.